Navigation Links
Leukemia Risk From MS Drug May Be Up
Date:4/30/2009

ds without symptoms. Eventually the disease can lead to loss of vision and paralysis.

Because research has shown that the drug can cause heart failure at high cumulative dosages as well as acute leukemia, doctors exercise caution when giving it to patients, said Patricia O'Looney, vice president of biomedical research for the National Multiple Sclerosis Society.

But the difficulty, she said, is that there are few other options for people with secondary progressive MS, and quality of life has to be balanced with risk of heart damage and leukemia.

"That's the frustrating part," O'Looney said. "When someone is reaching a very progressive form of the disease, and other drugs aren't working, we desperately need something in the clinical care of patients to try to help them. But there's no question about it. Novantrone is a strong drug, and with strong drugs, there are side effects."

Mitoxantrone is given in an IV infusion, usually in doses of 10 to 20 milligrams spaced about thee months apart.

Current U.S. guidelines call for people to receive a total lifetime dose of no more than 140 mg, O'Looney said.

People in the Italian study had received substantially less. Those who developed leukemia were given an average of 82 mg, compared with 63 mg for those who did not develop leukemia.

The leukemia occurred an average of three years after the first use of the drug and an average of 18 months after treatment had ended, according to the study.

"It is vital that all MS patients treated with mitoxantrone undergo prolonged and careful hematological follow-up to check for acute leukemia," Martinelli said.

In a second study to be presented at the meeting in Seattle, researchers found that adding the steroid methylprednisolone to treatment with interferon beta-1a (Avonex), a standard part of MS drug therapy, may reduce the amount of disease activity more than using the MS drug alone.

<
'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought
2. Researchers find drug that inhibits acute leukemia cell growth
3. Vince Papale and Eagles Fly for Leukemia Tee Up for a Cure at May 4, 2009 Celebrity Golf Classic and Auction
4. The Nations Triathlon to Benefit The Leukemia & Lymphoma Society is Sold Out But Theres Still a Way In!
5. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
6. Experimental agents may prevent radiation-induced leukemia
7. New biomarker may predict leukemia aggressiveness
8. Success of Colorful School Supply Collection Inspired by Leukemia Patient Kicks off Second Year
9. Enhancing the effects of the drug used to treat chronic myeloid leukemia
10. Scientists Identify Key Gene That Protects Against Leukemia
11. Families of Children Affected by Leukemia Get Boost of Support Thanks to Gift From Chrysler Jeep Superstores
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leukemia Risk From MS Drug May Be Up
(Date:7/7/2015)... ... July 07, 2015 , ... ... the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised more than ... original 2015 fundraising goal by nearly $100,000, to help support children fighting ...
(Date:7/7/2015)... ... July 07, 2015 , ... Ticket Down is a reputable source of authentic tickets ... the United States vs. Honduras at the Toyota Stadium. , The 2015 CONCACAF ... at Toyota Stadium. The tournament, being held on American soil, will kick off in Frisco, ...
(Date:7/7/2015)... Seattle, Washington (PRWEB) , ... ... ... and San Francisco-based Hope Consulting announced today that the two firms have ... organizations in the social, health and biopharma sectors. The merger combines SwitchPoint’s ...
(Date:7/7/2015)... ... 2015 , ... Celestix Networks, the leading provider of secure ... virtual appliances. These virtual platforms expand the existing physical appliances under the ... simplify the on-premises deployment of unified remote access and single sign-on (SSO). The ...
(Date:7/7/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, recently ... community through company-wide volunteering efforts. , On an annual basis, in coordination with ... in need throughout Baltimore and Washington D.C. , This year, SC&H Group’s ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:SC&H Group Celebrates 9th Annual Day of Service 2
... Caraco Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) ... (FDA) has granted final approval for the Company,s,Abbreviated ... 10 mg, 25 mg, 50 mg, 75 mg, ... is an antidepressant. Its use is indicated,to treat ...
... and ... Appropriate Treatment, FORT WORTH, ... launch of a new educational module "Chronic Wound,Infections", a CE ... treatment for improved clinical,outcomes., Chronic wounds substantially limit patient ...
... Facebook today announced,that Marc Andreessen has joined ... Ning, Andreessen is an investor in several,Internet startups., ... fortunate to have him join our,board," said Facebook ... is relevant to Facebook in so many ways: ...
... would be in new or renovated rooms; Unity and ... in serving West-side patients, ROCHESTER, N.Y., June 30 ... modernize and approve an,additional 140 beds -- more than 50 ... overcrowding -- according to a commission convened by,Finger Lakes Health ...
... Smart Balance, Inc.,(Nasdaq: SMBL ) announced today ... and Russell 3000(R) indexes. Russell,Investments reconstituted its comprehensive set ... "We are pleased to be included in the Russell ... a broader range of potential,investors," said Robert S. Gluck, ...
... June 30 The Justice Department,announced today a ... care,given to residents of the Beatrice State Developmental ... facility that serves almost 300,persons with mental retardation ... subject to the approval of the U.S. District,Court, ...
Cached Medicine News:Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R) 2Health News:The Wound Institute(R) Launches Educational Course on Chronic Wound Infections 2Health News:The Wound Institute(R) Launches Educational Course on Chronic Wound Infections 3Health News:The Wound Institute(R) Launches Educational Course on Chronic Wound Infections 4Health News:Marc Andreessen Joins Facebook Board of Directors 2Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 2Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 3Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 4Health News:Smart Balance Added to Russell 2000 and 3000 Indexes 2Health News:Justice Department Reaches Settlement to Improve Conditions at a Nebraska Developmental Center 2
(Date:7/7/2015)... PHILADELPHIA , July 7, 2015 ... and complex civil litigation law firm with one ... in the U.S, joined co-counsel Faruqi and Faruqi, ... lawsuits against pharmaceutical manufacturers AstraZeneca Pharmaceuticals LP, Cephalon, ... $55.5 million, plus statutory fees.  Under the agreements, ...
(Date:7/7/2015)... Kalifornien, 7. Juli 2015 Sequent ... sich der Entwicklung innovativer Geräte für die ... Zugang von R. Michael Kleine ... Herr Kleine verfügt über eine mehr als ... Gesundheitsfürsorge. Er hat verschiedene globale biomedizinische Unternehmen ...
(Date:7/7/2015)... 30, 2015 Research ... addition of the "The New Trends of ... their offering. The report, The New ... unique insights into the current development states and ... development outsourcing market. The report is designed to ...
Breaking Medicine Technology:AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5
... Phase II trial of a single,intraoperative administration of ... in the first 8 to 24 hours following,surgery, ... treatment.,The results of the multicenter, randomized, double-blind study ... Assembly in Anesthesiology in New York,City today, by ...
... Canada, Dec. 12 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... that identifies, develops and commercializes differentiated products for ... CIMYM BioSciences Inc. received a milestone payment from ... of the recent marketing approval of nimotuzumab in ...
Cached Medicine Technology:Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 4YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia 2YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia 3YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: